| Youth risk behavior surveillance—United States, 2011 H Wechsler MMWR Surveillence Summary 61, 1-162, 2012 | 14423* | 2012 |
| Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes H Getahun, M Harrington, R O'Brien, P Nunn The Lancet 369 (9578), 2042-2049, 2007 | 755 | 2007 |
| Central park W Benjamin, L Spencer, M Harrington New German Critique, 32-58, 1985 | 592 | 1985 |
| Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents Panel on Clinical Practices for Treatment of HIV Infection African journal of medical practice 5 (2), 79-104, 1998 | 499* | 1998 |
| The HIV-associated tuberculosis epidemic—when will we act? AD Harries, R Zachariah, EL Corbett, SD Lawn, ET Santos-Filho, ... The Lancet 375 (9729), 1906-1919, 2010 | 372 | 2010 |
| Building a tuberculosis-free world: The Lancet Commission on tuberculosis MJA Reid, N Arinaminpathy, A Bloom, BR Bloom, C Boehme, R Chaisson, ... The Lancet 393 (10178), 1331-1384, 2019 | 343 | 2019 |
| Hit HIV-1 hard, but only when necessary M Harrington, CCJ Carpenter The Lancet 355 (9221), 2147-2152, 2000 | 190 | 2000 |
| Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to action BJ Marais, MC Raviglione, PR Donald, AD Harries, AL Kritski, ... The Lancet 375 (9732), 2179-2191, 2010 | 169 | 2010 |
| From HIV to tuberculosis and back again: a tale of activism in 2 pandemics M Harrington Clinical Infectious Diseases 50 (Supplement_3), S260-S266, 2010 | 111 | 2010 |
| Randomized trials to optimize treatment of multidrug-resistant tuberculosis: the time for action is now CD Mitnick, KG Castro, M Harrington, LV Sacks, W Burman PLOS medicine 4 (11), e292, 2007 | 100 | 2007 |
| Promote HIV chemoprophylaxis research, don't prevent it RM Grant, S Buchbinder, W Cates Jr, E Clarke, T Coates, MS Cohen, ... Science 309 (5744), 2170-2171, 2005 | 99 | 2005 |
| Report of the NIH panel to define principles of therapy of HIV infection C Carpenter, M Feinberg, W Aubry, D Averitt, J Coffin, D Cooper, ... Annals of internal medicine 128 (12 PART 2), 1057-1078, 1998 | 47 | 1998 |
| Interim policy on collaborative TB/HIV activities H Getahun, J Van Gorkom, A Harries, M Harrington, P Nunn, J Perriens, ... World Health Organization, 2004 | 37 | 2004 |
| Fuel cell A Selcuk, N Maynard, M Harrington, K El Koury, A Baker, B Girvan US Patent 8,383,284, 2013 | 36 | 2013 |
| How research can help control tuberculosis [State of the art series. Tuberculosis. Edited by ID Rusen. Number 7 in the series] RE Chaisson, M Harrington The international journal of tuberculosis and lung disease 13 (5), 558-568, 2009 | 36 | 2009 |
| Feasibility of identifying household contacts of rifampin-and multidrug-resistant tuberculosis cases at high risk of progression to tuberculosis disease A Gupta, S Swindells, S Kim, MD Hughes, L Naini, X Wu, R Dawson, ... Clinical Infectious Diseases 70 (3), 425-435, 2020 | 35 | 2020 |
| Report of the NIH panel to define principles of therapy of HIV infection MB Feinberg Morbidity and Mortality Weekly Report: Recommendations and Reports, iv-38, 1998 | 31 | 1998 |
| Drug-resistant tuberculosis clinical trials: proposed core research definitions in adults J Furin, E Alirol, E Allen, K Fielding, C Merle, I Abubakar, J Andersen, ... The international journal of tuberculosis and lung disease 20 (3), 290-294, 2016 | 29 | 2016 |
| MSM, AIDS research activism, and HAART J Killen, M Harrington, AS Fauci The Lancet 380 (9839), 314-316, 2012 | 29 | 2012 |
| Time for zero deaths from tuberculosis S Keshavjee, M Harrington, G Gonsalves, L Chesire, PE Farmer The Lancet 378 (9801), 1449-1450, 2011 | 19 | 2011 |
